{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T14:40:55Z","timestamp":1789656055521,"version":"4.0.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T00:00:00Z","timestamp":1710720000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81870397"],"award-info":[{"award-number":["81870397"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Translational Autoimmunity"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.jtauto.2024.100239","type":"journal-article","created":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T00:54:31Z","timestamp":1710982471000},"page":"100239","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Autoantibodes to GP210 are a metric for UDCA responses in primary biliary cholangitis"],"prefix":"10.1016","volume":"8","author":[{"given":"Chan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuye","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaping","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luyao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyan","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhua","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sufang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingjuan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weifeng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2483-3878","authenticated-orcid":false,"given":"Suraj","family":"Timilsina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Eric","family":"Gershwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weichang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6208-4818","authenticated-orcid":false,"given":"Xiangdong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.jtauto.2024.100239_bib1","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1056\/NEJMra043898","article-title":"Primary biliary cirrhosis","volume":"353","author":"Kaplan","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.jtauto.2024.100239_bib2","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/hep.30145","article-title":"Primary biliary cholangitis: 2018 Practice guidance from the American association for the study of liver diseases","volume":"69","author":"Lindor","year":"2019","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.jtauto.2024.100239_bib3","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/liv.14791","article-title":"Anti-gp210 and other anti-nuclear pore complex autoantibodies in primary biliary cholangitis: what we know and what we should know","volume":"41","author":"Cristoferi","year":"2021","journal-title":"Liver Int. : official journal of the International Association for the Study of the Liver"},{"issue":"3","key":"10.1016\/j.jtauto.2024.100239_bib4","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1440-1746.1998.01553.x","article-title":"Autoantibodies against a 210 kDa glycoprotein of the nuclear pore complex as a prognostic marker in patients with primary biliary cirrhosis","volume":"13","author":"Itoh","year":"1998","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"3","key":"10.1016\/j.jtauto.2024.100239_bib5","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S0168-8278(00)00040-4","article-title":"Autoantibodies against nuclear pore complexes are associated with more active and severe liver disease in primary biliary cirrhosis","volume":"34","author":"Invernizzi","year":"2001","journal-title":"J. Hepatol."},{"issue":"5","key":"10.1016\/j.jtauto.2024.100239_bib6","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1002\/hep.21172","article-title":"Correlation of initial autoantibody profile and clinical outcome in primary biliary cirrhosis","volume":"43","author":"Wesierska-Gadek","year":"2006","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.jtauto.2024.100239_bib7","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/hep.21472","article-title":"Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis","volume":"45","author":"Nakamura","year":"2007","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.jtauto.2024.100239_bib8","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1111\/hepr.12423","article-title":"Autoantibody status and histological variables influence biochemical response to treatment and long-term outcomes in Japanese patients with primary biliary cirrhosis","volume":"45","author":"Nakamura","year":"2015","journal-title":"Hepatol. Res."},{"issue":"3","key":"10.1016\/j.jtauto.2024.100239_bib9","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.jhep.2004.11.016","article-title":"Antibody titer to gp210-C terminal peptide as a clinical parameter for monitoring primary biliary cirrhosis","volume":"42","author":"Nakamura","year":"2005","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.jtauto.2024.100239_bib10","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/liv.14688","article-title":"Antibodies to gp210 and understanding risk in patients with primary biliary cholangitis","volume":"41","author":"Haldar","year":"2021","journal-title":"Liver Int. : official journal of the International Association for the Study of the Liver"},{"issue":"5","key":"10.1016\/j.jtauto.2024.100239_bib11","first-page":"1123","article-title":"Prevalence, kinetics, and therapeutic modulation of autoantibodies against Sp100 and promyelocytic leukemia protein in a large cohort of patients with primary biliary cirrhosis","volume":"26","author":"Zuchner","year":"1997","journal-title":"Hepatology"},{"issue":"15\u201316","key":"10.1016\/j.jtauto.2024.100239_bib12","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.cca.2012.03.020","article-title":"Diagnostic and clinical utility of antibodies against the nuclear body promyelocytic leukaemia and Sp100 antigens in patients with primary biliary cirrhosis","volume":"413","author":"Mytilinaiou","year":"2012","journal-title":"Clinica chimica acta; international journal of clinical chemistry"},{"issue":"7","key":"10.1016\/j.jtauto.2024.100239_bib13","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3109\/08916934.2013.801461","article-title":"Clinical significance of the fluctuation of primary biliary cirrhosis-related autoantibodies during the course of the disease","volume":"46","author":"Gatselis","year":"2013","journal-title":"Autoimmunity"},{"issue":"1","key":"10.1016\/j.jtauto.2024.100239_bib14","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/hep.510250103","article-title":"Quantitative measurement of autoantibodies to recombinant mitochondrial antigens in patients with primary biliary cirrhosis: relationship of levels of autoantibodies to disease progression","volume":"25","author":"Van Norstrand","year":"1997","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.jtauto.2024.100239_bib15","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1309\/AJCPQV4A7QAEEFEV","article-title":"The significance of autoantibody changes over time in primary biliary cirrhosis","volume":"144","author":"Tana","year":"2015","journal-title":"Am. J. Clin. Pathol."},{"issue":"2","key":"10.1016\/j.jtauto.2024.100239_bib16","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s12016-021-08904-y","article-title":"Antimitochondrial antibodies: from Bench to Bedside","volume":"63","author":"Colapietro","year":"2022","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"8","key":"10.1016\/j.jtauto.2024.100239_bib17","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1111\/hepr.12423","article-title":"Autoantibody status and histological variables influence biochemical response to treatment and long-term outcomes in Japanese patients with primary biliary cirrhosis","volume":"45","author":"Nakamura","year":"2015","journal-title":"Hepatol. Res. : the official journal of the Japan Society of Hepatology"},{"issue":"3","key":"10.1016\/j.jtauto.2024.100239_bib18","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1440-1746.1998.01553.x","article-title":"Autoantibodies against a 210 kDa glycoprotein of the nuclear pore complex as a prognostic marker in patients with primary biliary cirrhosis","volume":"13","author":"Itoh","year":"1998","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"6","key":"10.1016\/j.jtauto.2024.100239_bib19","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1200\/JCO.2014.57.9151","article-title":"Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade","volume":"33","author":"Johnson","year":"2015","journal-title":"J. Clin. Oncol. : official journal of the American Society of Clinical Oncology"},{"issue":"5","key":"10.1016\/j.jtauto.2024.100239_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhepr.2021.100347","article-title":"ALBI grade: evidence for an improved model for liver functional estimation in patients with hepatocellular carcinoma","volume":"3","author":"Demirtas","year":"2021","journal-title":"JHEP reports : innovation in hepatology"},{"issue":"6","key":"10.1016\/j.jtauto.2024.100239_bib21","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/j.jhep.2011.02.031","article-title":"Early primary biliary cirrhosis: biochemical response to treatment and prediction of long-term outcome","volume":"55","author":"Corpechot","year":"2011","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jtauto.2024.100239_bib22","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms14828","article-title":"A genome-wide association study identifies six novel risk loci for primary biliary cholangitis","volume":"8","author":"Qiu","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jtauto.2024.100239_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.jim.2021.113211","article-title":"Increased sensitivity of gp210 autoantibody detection using a newly designed gp210 antigen","volume":"501","author":"Xu","year":"2022","journal-title":"J. Immunol. Methods"},{"issue":"1","key":"10.1016\/j.jtauto.2024.100239_bib24","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/hep.30604","article-title":"Genome-wide association studies of specific antinuclear autoantibody Subphenotypes in primary biliary cholangitis","volume":"70","author":"Wang","year":"2019","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.jtauto.2024.100239_bib25","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1136\/gut.17.11.844","article-title":"Immune response to phi X 174 in man. 5. Primary and secondary antibody production in primary biliary cirrhosis","volume":"17","author":"Thomas","year":"1976","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.jtauto.2024.100239_bib26","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1084\/jem.178.6.2237","article-title":"Autoantibodies from patients with primary biliary cirrhosis recognize a restricted region within the cytoplasmic tail of nuclear pore membrane glycoprotein Gp210","volume":"178","author":"Nickowitz","year":"1993","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.jtauto.2024.100239_bib27","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1136\/gutjnl-2016-313332","article-title":"Gut microbial profile is altered in primary biliary cholangitis and partially restored after UDCA therapy","volume":"67","author":"Tang","year":"2018","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.jtauto.2024.100239_bib28","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/hep.1840110404","article-title":"Mechanism of gamma-glutamyl transpeptidase release in serum during intrahepatic and extrahepatic cholestasis in the rat: a histochemical, biochemical and molecular approach","volume":"11","author":"Bulle","year":"1990","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.jtauto.2024.100239_bib29","first-page":"262","article-title":"Serum gamma glutamyl transferase as a specific indicator of bile duct lesions in the rat liver","volume":"116","author":"Leonard","year":"1984","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.jtauto.2024.100239_bib30","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s12876-019-1075-0","article-title":"Association between serum IgG level and clinical course in primary sclerosing cholangitis","volume":"19","author":"Hippchen","year":"2019","journal-title":"BMC Gastroenterol."},{"issue":"8","key":"10.1016\/j.jtauto.2024.100239_bib31","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1097\/MCG.0b013e318154af74","article-title":"Serologic markers compared with liver biopsy for monitoring disease activity in autoimmune hepatitis","volume":"42","author":"Luth","year":"2008","journal-title":"J. Clin. Gastroenterol."},{"issue":"3","key":"10.1016\/j.jtauto.2024.100239_bib32","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1053\/jhep.2002.36088","article-title":"Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited","volume":"36","author":"Paumgartner","year":"2002","journal-title":"Hepatology"},{"issue":"Suppl 3","key":"10.1016\/j.jtauto.2024.100239_bib33","first-page":"S412","article-title":"Predictive role of anti-gp210 and anticentromere antibodies in long-term outcome of primary biliary cirrhosis","volume":"37","author":"Nakamura","year":"2007","journal-title":"Hepatol. Res."},{"issue":"3","key":"10.1016\/j.jtauto.2024.100239_bib34","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1365-2249.2012.04577.x","article-title":"Epitope-specific anti-nuclear antibodies are expressed in a mouse model of primary biliary cirrhosis and are cytokine-dependent","volume":"168","author":"Yang","year":"2012","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jtauto.2024.100239_bib35","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/7111445","article-title":"The proinflammatory cytokines IL-18, IL-21, and IFN-gamma differentially regulate liver inflammation and anti-mitochondrial antibody level in a murine model of primary biliary cholangitis","volume":"2022","author":"Xu","year":"2022","journal-title":"Journal of immunology research"}],"container-title":["Journal of Translational Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589909024000091?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589909024000091?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,16]],"date-time":"2024-06-16T21:44:58Z","timestamp":1718574298000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589909024000091"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":35,"alternative-id":["S2589909024000091"],"URL":"https:\/\/doi.org\/10.1016\/j.jtauto.2024.100239","relation":{},"ISSN":["2589-9090"],"issn-type":[{"value":"2589-9090","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoantibodes to GP210 are a metric for UDCA responses in primary biliary cholangitis","name":"articletitle","label":"Article Title"},{"value":"Journal of Translational Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtauto.2024.100239","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100239"}}